Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients with Unresectable Locally Advanced or Metastatic Urothelial Cancer
Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation CHARM
Phase I Trial with Expansion Cohort of OBP-301 Telomelysin and Definitive Chemoradiation for Patients with Locally Advanced Esophageal and Gastroesophageal Adenocarcinoma Who Are Not Candidates for Surgery
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring STMDDM versus Usual Care in Patients with Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
A Phase 3 Trial Investigating Blinatumomab NSC 765986 in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia B-ALL and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma B-LLy
Study Type: Treatment
Phase: III
NCTID: NCT03914625
Principal Investigator:
Keith August
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-cell Treatment for Relapsed/Refractory Large B-cell Lymphoma or Grade IIIB Follicular Lymphoma
Study Type: Treatment
Phase: II
NCTID: NCT05633615
Principal Investigator:
Marc Hoffmann
A Randomized Phase III Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy
Prospective, Interventional Pilot Study of Mobile Devices and Digital Applications to Detect Early Pneumonitis and Other Pulmonary Adverse Events Causing Treatment Discontinuations in Unresectable Stage III Non-Small Cell Lung Cancer Patients on Durvalumab
V-FAST: A Phase IB Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Subjects with Previously Untreated Acute Myeloid Leukemia
Feasibility Study of Resection and GammaTile Followed by Concomitant External Beam Radiation Therapy EBRT and Temozolomide TMZ and Adjuvant TMZ in Newly Diagnosed Glioblastoma GBM.
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT05342883
Principal Investigator:
Tolga Tuncer